The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Infinity Pharmaceuticals Inc

Nasdaq: INFI
Last

(U.S.) $1.72

Today's change-0.02 -1.15%
Updated May 26 4:00 PM EDT. Delayed by at least 15 minutes.
 

Infinity Pharmaceuticals Inc

Nasdaq: INFI
Last

(U.S.) $1.72

Today's change-0.02 -1.15%
Updated May 26 4:00 PM EDT. Delayed by at least 15 minutes.

Infinity Pharmaceuticals Inc down (U.S.)$0.02

Infinity Pharmaceuticals Inc closed lower Friday, dropping (U.S.)$0.02 or 1.15% to (U.S.)$1.72. Shares have lost 3.37% over the last five days, but have gained 27.41% over the last year to date. This security has underperformed the S&P 500 by 82.25% during the last year.

Key company metrics

  • Open(U.S.) $1.74
  • Previous close(U.S.) $1.74
  • High(U.S.) $1.74
  • Low(U.S.) $1.69
  • Bid / Ask(U.S.) $1.35 / (U.S.) $2.10
  • YTD % change+27.41%
  • Volume215,233
  • Average volume (10-day)319,141
  • Average volume (1-month)668,738
  • Average volume (3-month)1,093,021
  • 52-week range(U.S.) $0.84 to (U.S.) $5.79
  • Beta2.60
  • Trailing P/E131.80×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.01
Updated May 26 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.04%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue0009
Total other revenue--------
Total revenue0009
Gross profit--------
Total cost of revenue--------
Total operating expense102320-44
Selling / general / administrative69716
Research & development4151353
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-10-23-2053
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-10-23-1953
Income after tax-10-23-1953
Income tax, total--00--
Net income-10-23-1953
Total adjustments to net income--------
Net income before extra. items-10-23-1953
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-10-23-1953
Inc. avail. to common incl. extra. items-10-23-1953
Diluted net income-10-23-1953
Dilution adjustment------0
Diluted weighted average shares50505049
Diluted EPS excluding extraordinary itemsvalue per share-0.21-0.46-0.391.07
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.21-0.46-0.391.07